Ligand validation:4MO5

AH0: 2-(2-ACETYLAMINO-4-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCT-3-YLOXY)-PROPIONIC ACID

AH0 is a Ligand Of Interest in 4MO5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4MO5_AH0_C_401	97%	76%	0.061	0.974	0.22	0.72	-	1	0	0	100%	1
4MO5_AH0_B_401	94%	90%	0.062	0.961	0.17	0.43	-	-	0	0	100%	1
4MO5_AH0_D_401	92%	88%	0.069	0.961	0.19	0.48	-	-	0	0	100%	1
4MO5_AH0_A_401	84%	91%	0.074	0.934	0.16	0.42	-	-	0	0	100%	1
8CPB_AH0_A_402	90%	44%	0.072	0.954	1.21	0.98	3	1	0	0	100%	1
3QBX_AH0_B_654	75%	12%	0.13	0.962	1.61	2.4	3	9	0	0	100%	1
6FCR_AH0_G_101	76%	11%	0.134	0.972	0.83	3.3	-	5	0	0	100%	0.9474
6FBT_AH0_E_101	72%	7%	0.134	0.959	0.81	3.98	-	10	0	0	100%	0.9474
1QTE_AH0_A_652	21%	33%	0.133	0.752	1.28	1.39	2	4	0	0	95%	0.9474

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.